It's May 25, 2024, 03:27:06 AM
In PRP therapy, which was pioneered over the last decade by Dr. Allan Mishra of the Stanford University Medical Center, about two tablespoons of a patient’s blood are removed and put through a centrifuge. This creates a concentrated dose of soft-tissue-healing platelets that is then reinjected into the patient [at the site of an injury]. In part because no red blood cells are reinjected, PRP treatments are not considered blood doping.
DB: Is there a reason he went to Germany, is this not approved yet in the USA or still in the process of getting approved?Dr. Raj: I think the biggest reason he went to Germany is because in the US there has been a lot of controversy about the usage of PRP. We’ve had a lot of physicians start using it without understanding why and what they are using it for and for what indications. Because of that, there is a lack of data. In Europe, especially Germany, they tend to be a lot more advanced and a lot more accepting and don’t have as strong of regulatory factors as we do here in the USA. I would suspect because of the proven data and the data out there in Germany, that’s probably why he went to Germany to get this done